D. K. Salim Et Al. , "Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.," Molecular and clinical oncology , vol.3, pp.839-842, 2015
Salim, D. K. Et Al. 2015. Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.. Molecular and clinical oncology , vol.3 , 839-842.
Salim, D. K., Mutlu, H., Eryilmaz, M. K., Salim, O., Musri, F. Y., Tural, D., ... Gündüz, Ş.(2015). Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.. Molecular and clinical oncology , vol.3, 839-842.
Salim, Derya Et Al. "Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.," Molecular and clinical oncology , vol.3, 839-842, 2015
Salim, Derya K. Et Al. "Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.." Molecular and clinical oncology , vol.3, pp.839-842, 2015
Salim, D. K. Et Al. (2015) . "Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.." Molecular and clinical oncology , vol.3, pp.839-842.
@article{article, author={Derya Kivrak Salim Et Al. }, title={Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.}, journal={Molecular and clinical oncology}, year=2015, pages={839-842} }